Skip to content
MedsAcross

Medicine

Folic acid 1 mg tablet

Folic acid · Oral
Available on requestPrescription onlyUS FDAGeneric name

Folic acid 1 mg tablet is a generic prescription medicine for oral use, made by 26 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store 20°-25°C (68°-77°F).

Key facts

Active ingredient (INN)
Folic acid
Brand
Sold under the generic name
Strength
1 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 1000 tablets, 10 tablets and 133 more
Manufacturers
Cadila PharmaceuticalsIndiaBryant Ranch PrepackChartwell RXAmneal PharmaceuticalsSunrise PharmaceuticalAmneal Pharmaceuticals of New YorkLeading PharmaMethod PharmaceuticalsModavar PharmaceuticalsQuagen Pharmaceuticals26 labelers on the register
Origin register
US FDA, United States
Storage
Store 20°-25°C (68°-77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
B03BB01 Folic acid
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
12 January 2009
Identifiers
RxCUI 310410DailyMed set ID 1383dce2-0b81-4694-a662-27576f867eae, f8ffce0d-2b94-4a14-a08e-97646436cf6d, 0eea15e4-7e5d-44e9-818b-a0bdf5271c78 +37NDC 71335-2849, 71610-716, 72241-050 +37Application ANDA211064, ANDA202437, ANDA204418 +4

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 26 labelers. The register lists 136 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet in 1 bottle71209-007-05Cadila PharmaceuticalsIndia20 November 2018
1000 tablet in 1 bottle71209-007-11Cadila PharmaceuticalsIndia20 November 2018
10 tablet in 1 bottle65162-361-01Amneal Pharmaceuticals2 December 2009
100 tablet in 1 bottle65162-361-10Amneal Pharmaceuticals2 December 2009
1000 tablet in 1 bottle65162-361-11Amneal Pharmaceuticals2 December 2009
500 tablet in 1 bottle65162-361-50Amneal Pharmaceuticals2 December 2009
100 tablet in 1 bottle53746-361-01Amneal Pharmaceuticals of New York7 March 2022
1000 tablet in 1 bottle53746-361-10Amneal Pharmaceuticals of New York7 March 2022
100 tablet in 1 bottle62135-210-01Chartwell RX30 May 2019
500 tablet in 1 bottle62135-210-05Chartwell RX9 March 2022
1000 tablet in 1 bottle62135-210-10Chartwell RX30 May 2019
1800 tablet in 1 bottle62135-210-72Chartwell RX3 March 2022
90 tablet in 1 bottle62135-210-90Chartwell RX3 March 2022
3000 tablet in 1 bottle62135-210-97Chartwell RX30 May 2019
100 tablet in 1 bottle69315-127-01Leading Pharma21 February 2018
1000 tablet in 1 bottle69315-127-10Leading Pharma21 February 2018
100 tablet in 1 bottle58657-151-01Method Pharmaceuticals25 January 2021
1000 tablet in 1 bottle58657-151-10Method Pharmaceuticals25 January 2021
100 tablet in 1 bottle72241-050-05Modavar Pharmaceuticals20 November 2018
1000 tablet in 1 bottle72241-050-11Modavar Pharmaceuticals20 November 2018
100 tablet in 1 bottle70752-231-10Quagen Pharmaceuticals10 July 2023
1000 tablet in 1 bottle70752-231-11Quagen Pharmaceuticals10 July 2023
100 tablet in 1 bottle16571-881-01Rising Pharma Holdings25 October 2022
1000 tablet in 1 bottle16571-881-10Rising Pharma Holdings25 October 2022
100 tablet in 1 bottle11534-165-01Sunrise Pharmaceutical4 August 2015
1000 tablet in 1 bottle11534-165-03Sunrise Pharmaceutical4 August 2015
90 tablet in 1 bottle11534-165-90Sunrise Pharmaceutical29 September 2017
100 tablet in 1 bottle63629-9257-1Bryant Ranch Prepack25 January 2021
1000 tablet in 1 bottle63629-9258-1Bryant Ranch Prepack25 January 2021
30 tablet in 1 bottle71335-0613-1Bryant Ranch Prepack14 July 2021
100 tablet in 1 bottle71335-0613-2Bryant Ranch Prepack9 June 2021
120 tablet in 1 bottle71335-0613-3Bryant Ranch Prepack28 January 2025
50 tablet in 1 bottle71335-0613-4Bryant Ranch Prepack28 January 2025
90 tablet in 1 bottle71335-0613-5Bryant Ranch Prepack28 January 2025
60 tablet in 1 bottle71335-0613-6Bryant Ranch Prepack28 January 2025
10 tablet in 1 bottle71335-0613-7Bryant Ranch Prepack28 January 2025
30 tablet in 1 bottle71335-0766-1Bryant Ranch Prepack10 April 2018
100 tablet in 1 bottle71335-0766-2Bryant Ranch Prepack10 April 2018
120 tablet in 1 bottle71335-0766-3Bryant Ranch Prepack10 April 2018
50 tablet in 1 bottle71335-0766-4Bryant Ranch Prepack10 April 2018

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 2 June 1947Drugs@FDA
EU (EMA)Application withdrawnEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Folic acid

Clinical summary

Folic acid is a prescription medicine indicated for the treatment of megaloblastic anemias due to folic acid deficiency in adult and pediatric patients. MedsAcross supplies Folic acid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Folic acid

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Folic acid 1 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.